Importer of Controlled Substances Registration: Meda Pharmaceuticals, Inc., 60501 [2014-23828]

Download as PDF 60501 Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices with 21 CFR 1301.34, the above-named company is granted registration as an importer of the basic classes of controlled substances: Controlled substance Schedule Mephedrone (4-Methyl-Nmethylcathinone) (1248). 1-Pentyl-3-(1-naphthoyl)indole) (7118). 5-(1,1-Dimethylheptyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7297). Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... 4-Bromo-2,5dimethoxyamphetamine (7391). 3,4Methylenedioxymethamphetamine (7405). Dimethyltryptamine (7435) ........... Psilocyn (7438) ............................. Amphetamine (1100) .................... Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Phencyclidine (7471) .................... Cocaine (9041) ............................. Oxycodone (9143) ........................ Thebaine (9333) ........................... Fentanyl (9801) ............................ I I I I I I I I I II II II II II II II II The company plans to import the listed controlled substances in dosage form to distribute to researchers. In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activity for these drug codes is authorized for this registration. The import of the above listed basic classes of controlled substances would be granted only for analytical testing and clinical trials. This authorization does not extend to the import of a finished Food and Drug Administration approved or non-approved dosage form for commercial distribution in the United States. Dated: September 26, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. substance. The DEA grants Meda Pharmaceuticals, Inc., registration as an importer of this controlled substance. SUPPLEMENTARY INFORMATION: By notice dated June 10, 2014, and published in the Federal Register on June 17, 2014, 79 FR 34552, Meda Pharmaceuticals, Inc., 705 Eldorado Street, Decatur, Illinois 62523, applied to be registered as an importer of a certain basic class of controlled substance. No comments or objections were submitted for this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Meda Pharmaceuticals, Inc., to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of nabilone (7379), a basic class of controlled substance listed in schedule II. The company plans to import the FDA approved listed controlled substance as a finished drug product in dosage form for distribution to its customers. Dated: September 26, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–23828 Filed 10–6–14; 8:45 am] [FR Doc. 2014–23829 Filed 10–6–14; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] DEPARTMENT OF JUSTICE Importer of Controlled Substances Application: Chattem Chemicals, Inc. asabaliauskas on DSK5VPTVN1PROD with NOTICES [Docket No. DEA–392] ACTION: Importer of Controlled Substances Registration: Meda Pharmaceuticals, Inc. ACTION: Notice of registration. Meda Pharmaceuticals, Inc., applied to be registered as an importer of a certain basic class of controlled SUMMARY: VerDate Sep<11>2014 17:15 Oct 06, 2014 Jkt 235001 Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 6, 2014. Such persons may also file a written request DATES: PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of importers, of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on June 23, 2014, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Chattanooga, Tennessee 37409, applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance BILLING CODE 4410–09–P Drug Enforcement Administration for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 6, 2014. Methamphetamine (1105) ............ 4-Anilino-N-phenethyl-4-piperidine (8333). Phenylacetone (8501) .................. Thebaine (9333) ........................... Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) Tapentadol (9780) ........................ Schedule II II II II II II II The company plans to import the listed controlled substances to manufacture bulk controlled substances for sale to its customers. The company plans to import an intermediate form of Tapentadol (9780), and Thebaine (9333), for the manufacture of other bulk controlled substances and distribution to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). E:\FR\FM\07OCN1.SGM 07OCN1

Agencies

[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Page 60501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23828]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Meda 
Pharmaceuticals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Meda Pharmaceuticals, Inc., applied to be registered as an 
importer of a certain basic class of controlled substance. The DEA 
grants Meda Pharmaceuticals, Inc., registration as an importer of this 
controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated June 10, 2014, and published 
in the Federal Register on June 17, 2014, 79 FR 34552, Meda 
Pharmaceuticals, Inc., 705 Eldorado Street, Decatur, Illinois 62523, 
applied to be registered as an importer of a certain basic class of 
controlled substance. No comments or objections were submitted for this 
notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Meda Pharmaceuticals, Inc., to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of nabilone (7379), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the FDA approved listed controlled 
substance as a finished drug product in dosage form for distribution to 
its customers.

    Dated: September 26, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-23828 Filed 10-6-14; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.